Dmitry Vinogradov Glaukos Corporation (NYSE:GKOS) traded lower on Wednesday after Citi downgraded the glaucoma product maker to neutral from buy as part of a review of its U.S. MedTech coverage ahead of Q2 2024 results. Analyst Joanne Wuensch argued that Glaukos (GKOS), which has climbed more than 50% this year,Continue Reading
jetcityimage Bank of America Securities downgraded Visa (NYSE:V) and Mastercard (NYSE:MA) to Neutral from Buy as analyst Jason Kupferberg sees limited upside potential to the two payment networks’ valuation multiples and estimates. “Investor positioning remains crowded. Regulatory developments could limit multiple expansion and V/MA’s ability to take price,” the analystContinue Reading
monsitj/iStock via Getty Images Gold futures extended recent gains to jump to six-week highs Friday, as the June jobs report that showed an increase in the unemployment rate to 4.1% was seen as a sign that high interest rates are slowing down the economy. There were other indications that couldContinue Reading
Funtap Real estate investment trusts, or REITs, continued to lower their net asset value discount in June as investor sentiment improved on the back of increased hopes for a near-term rate cut. Traders see a 66.5% probability of a September 25-basis-point rate cut now, compared to 47.0% at the beginningContinue Reading
CureVac N.V. (NASDAQ:CVAC) to cut its workforce by 30% as part of a restructuring initiative, as GSK (NYSE:GSK) acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, for €1.45 billion plus royalties. The new agreement extends CureVac’s (CVAC) cash runway into 2028, asContinue Reading
Walgreen’s Boots Alliance (NASDAQ:WBA) shares are set to open lower for a fifth consecutive day as the company’s decision to close a “substantial” number of U.S. stores continues to weigh on the stock. The company was subsequently hit with a wave of price target adjustments, the latest from BofA Securities,Continue Reading
Nike (NYSE:NKE) shares are reversing a knee-jerk reaction higher and losing ground after remarks from the company’s CFO acknowledging macro challenges hinted to a guidance cut, and FQ4 revenue was worse than Wall Street expected. Shares are down 5%, dragging down Foot Locker (FL) by 3% in sympathy. The sportswearContinue Reading
Pgiam/iStock via Getty Images Oppenheimer downgraded respiratory device maker ResMed (NYSE:RMD) to Perform from Outperform on Tuesday, citing an “air pocket” for the stock in the wake of encouraging data for Eli Lilly’s (NYSE:LLY) weight loss therapy tirzepatide in obstructive sleep apnea (OSA). The maker of CPAP (continuous positive airwayContinue Reading
Investing.com–Bitcoin price climbed on Monday but remained largely rangebound despite optimism over potential interest rate cuts by major central banks this week and weakness in the dollar. rose 1.5% in the past 24 hours to $69,253.8 by 08:18 ET (12:18 GMT). But the world’s largest cryptocurrency remained well within aContinue Reading
